Vineet Laboratories Limited — Important, 15-12-2025: Committee Meeting Updates

Vineet Laboratories' Rights Issue Committee meeting was adjourned and will reconvene. This temporary pause allows the Committee to thoroughly consider and finalize critical details for the proposed Rights Issue. These include the issue price, the entitlement ratio, and the important opening and closing dates for the issue. This decision-making process is contingent upon the company first securing in-principle approval from BSE Ltd., a necessary regulatory step before moving forward with the capital raise plan.